0 CHECKOUT

PRODUCT FILTERS

REGION

1,214
582
579
524
524

COUNTRY

510
126
54
52
51

CATEGORIES

  • 314
  • 245
  • 234
  • 234
  • 211
  • 170
  • 161
  • 161
  • 140
  • 137
  • 135
  • 127
  • 80
  • 74
  • 42

PRICE

367
1,006
1,526
3,442

PUBLISHED

561
980
1,615
3,442

PRODUCT TYPE

2,630
358
287
136
26
2
1
1
1

Oncology Drugs

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

Vulvar Cancer-Pipeline Insights, 2016

“ Vulvar Cancer-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Vulvar Cancer. The report covers the product profiles in various...

Published:  March 2016
Price:  From

Non-Small Cell Lung Carcinoma-Pipeline Insights, 2016

“ Non-Small Cell Lung Carcinoma-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Non-Small Cell Lung Carcinoma. The report covers...

Published:  March 2016
Price:  From

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2016

“ Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Non Muscle...

Published:  March 2016
Price:  From

Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2016

“ Non Muscle Invasive Bladder Cancer (NMIBC)-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Non Muscle Invasive Bladder Cancer...

Published:  March 2016
Price:  From

Transitional Cell Carcinoma (Urothelial Cell Carcinoma)-Pipeline Insights, 2016

“ Transitional Cell Carcinoma (Urothelial Cell Carcinoma)-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Transitional Cell Carcinoma...

Published:  March 2016
Price:  From

Transitional Cell Cancer (Urothelial Cell Cancer)-Pipeline Insights, 2016

“ Transitional Cell Cancer (Urothelial Cell Cancer)-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Transitional Cell Cancer (Urothelial...

Published:  March 2016
Price:  From

Thrombocythaemia Myelofibrosis-Pipeline Insights, 2016

“ Thrombocythaemia Myelofibrosis-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Thrombocythaemia Myelofibrosis. The report covers...

Published:  March 2016
Price:  From

Papillary Thyroid Cancer-Pipeline Insights, 2016

“ Papillary Thyroid Cancer-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Papillary Thyroid Cancer. The report covers the product...

Published:  March 2016
Price:  From

Medullary Thyroid Cancer-Pipeline Insights, 2016

“ Medullary Thyroid Cancer-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Medullary Thyroid Cancer. The report covers the product...

Published:  March 2016
Price:  From

Medullary Thyroid Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Medullary Thyroid Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III...

Published:  March 2016
Price:  From

Anaplastic Thyroid Cancer-Pipeline Insights, 2016

“ Anaplastic Thyroid Cancer-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Anaplastic Thyroid Cancer. The report covers the product...

Published:  March 2016
Price:  From

Thyroid Cancer-Pipeline Insights, 2016

“ Thyroid Cancer-Pipeline Insights, 2016” provides in depth insight on the pipeline drugs and their development activities around the Thyroid Cancer. The report covers the product profiles in various...

Published:  March 2016
Price:  From

Thyroid Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Thyroid Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From

Tumor Necrosis Factor Receptor (TNFR) Antagonists -Pipeline Insights, 2016

SUMMARY The report, “Tumor Necrosis Factor Receptor (TNFR) Antagonists-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Tumor Necrosis...

Published:  March 2016
Price:  From

Tumor Necrosis Factor Alpha (TNF-a) Agonists -Pipeline Insights, 2016

SUMMARY The report, “Tumor Necrosis Factor Alpha (TNF-a) Agonists-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Tumor Necrosis...

Published:  March 2016
Price:  From

Tumor Necrosis Factor (TNF) Inhibitors -Pipeline Insights, 2016

SUMMARY The report, “Tumor Necrosis Factor (TNF) Inhibitors-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Tumor Necrosis Factor...

Published:  March 2016
Price:  From

Tumor Necrosis Factor (TNF) Agonists -Pipeline Insights, 2016

SUMMARY The report, “Tumor Necrosis Factor (TNF) Agonists-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the Tumor Necrosis Factor...

Published:  March 2016
Price:  From

20s Proteasome Inhibitors -Pipeline Insights, 2016

SUMMARY The report, “20s Proteasome Inhibitors-Pipeline Insights, 2016” provides in depth insights on the pipeline drugs and their development activities around the 20s Proteasome Inhibitors. The...

Published:  March 2016
Price:  From

Small-Cell Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Small-Cell Lung Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III...

Published:  March 2016
Price:  From

Testicular Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

SUMMARY The Report, “Testicular Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline...

Published:  March 2016
Price:  From
Loading Indicator

Our Clients